What is hTEE ? with ImaCor's Dr. Scott Roth (video)

ImaCor In the Cardiac Industry

ImaCor is know in the cardiac industry as "The Clear Direction in Hemodynamic Management", and the company was founded in 2000 dedicated to improving patient care in the intensive care and perioperative areas of hospitals. ImaCor designs, manufactures and distributes advanced solutions for assessing and monitoring cardiac function in ICU and perioperative patients.

In this film, ImaCor Co-Founder and Chief Medical Officer Scott L. Roth discusses the development of the world’s first imaging monitor that enables the assessment and monitoring of cardiac function in critically ill patients. The ClariTEE™, a miniaturized disposable TEE probe, enables direct visualization of cardiac function and can remain indwelling for up to 72-hours.

Dr. Scott Roth holds a B.A. in biology, summa cum laude, and an M.D. from Boston University. He completed his internship and residency in internal medicine at Montefiore Hospital and his cardiovascular disease fellowship at Long Island Jewish Medical Center. Dr. Roth has been practicing medicine for over 20 years and is affiliated with Long Island Jewish Medical Center, North Shore University Hospital, and the New York Hospital Medical Center of Queens. Dr. Roth maintained a private echocardiography practice for 20 years until taking over as CEO of ImaCor. Dr. Roth co-founded ImaCor and now serves as Chief Medical Officer. He has published a dozen articles in the fields of cardiology and echocardiography. He is a founding board member of the New York Echocardiography Society and was the former Director of Adult Echocardiography at the Harris Chasanoff Heart Institute at Long Island Jewish Medical Center.